MRC Epidemiology Unit

 

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.

Califf RM, Boolell M, Haffner SM, Bethel M, McMurray J, Duggal A, Holman RR

American heart journal. Oct 2008

(DOI : 10.1016/j.ahj.2008.05.017)

---